Infectious Disease Immunoassay Market by Product & Services, Specimen Type, Disease, Platform, End User & 2023

Infectious Disease Immunoassay Market by Product & Services (Reagents and kits, Analysers & Software and Services), Platform (CLIA, FIA, CI, RIA), Specimen Type, Disease (Hepatitis, HIV, CT/NG, HPV, TB, Influenza) & End User - Global Forecast to 2023

Report Code: UC 1961 May, 2024, by marketsandmarkets.com

The global infectious disease immunoassay market is expected to reach USD 2,233.0 million by 2023 from USD 1,642.5 million in 2018, growing at a CAGR of 6.3%. Increasing incidence of chronic and infectious diseases; technological advancements in immunoassay instruments and the introduction of novel automated systems; growth in biotechnology and biopharmaceutical industries; increasing adoption of immunoassay-based point-of-care testing and rapid testing are some of the major factors driving the growth of the global infectious disease immunoassay market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.

North America dominates the infectious disease immunoassay market with the North America accounted major market share in 2017. Established healthcare infrastructure; and technological advancements in immunoassay instrumentation are some of the major driving factors driving the growth of this market in North America. The Asian infectious disease immunoassay market is poised to grow at the highest CAGR during the forecast period owing to improving healthcare infrastructure and rising awareness about advanced point-of-care diagnostics among people in the region. The rising focus of prominent players on the Asian infectious disease immunoassay market is another factor driving its growth. Furthermore, emerging countries such as India and China provides immense growth opportunities to the infectious disease immunoassay manufacturers.

Prominent players in the infectious disease immunoassay market are Abbott Laboratories, Inc., Siemens AG, Beckman Coulter, Inc., Sysmex Corporation, Biomerieux Sa, Ortho Clinical Diagnostics, Inc., DiaSorin, QIAGEN N.V, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Agilent Technologies.

Get online access to the report on the World's First Market Intelligence Cloud
Easy to Download Historical Data & Forecast Numbers
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Request Sample

Click on image to enlarge

Scope of the Report

This research report covers the global suture anchor device market by method; product & services; platform; specimen type; disease type; end user; and geography.

Infectious Disease Immunoassay Market, by Product Type

Reagents & Kits
- ELIZA
- Rapid Tests
- ELISPOT
- Western Blot
- Other reagents and kits
Analyzers
- Open-ended systems
- Closed-ended systems
Software And Services

Infectious Diseases Immunoassay Market, BY Platform

Chemiluminescence Immunoassay (CLIA)
Fluorescence Immunoassay (FIA)
Colorimetric Immunoassay (CI)
Radioimmunoassay (RIA)
Other Platfoms

Infectious Disease Immunoassay market, by Specimen Type

Blood
Saliva
Urine
Other

Infectious Diseases Immunoassay market, by Disease type

Hepatitis
hiv
ct/ng
hais
HPV
TB
Influenza
Other

Infectious Diseases Immunoassay market, by End User

Hospitals and Clinical Laboratories
Pharmaceutical and Biotechnology Companies & Cros
Academic & Research Laboratories
Other End Users

Infectious Disease Immunoassay market, BY region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Rest Of Europe (Roe)
Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
Latin America
Middle East & Africa

Table of Contents

1 Introduction
    1.1 Objective of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data Points Taken From Secondary Sources
           2.3.2 Key Data Points Taken From Primary Sources
    2.4 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 Infectious Diesease Immunoassay Market, By Products and Services
    6.1 Introduction
    6.2 Reagents & Kits
           6.2.1 Elisa
           6.2.2 Rapid Tests
           6.2.3 Elispot
           6.2.4 Western Blot
           6.2.5 Other Reagents and Kits
    6.3 Analyzers
           6.3.1 Open-Ended Systems
           6.3.2 Close-Ended Systems
    6.4 Software & Services

7 Infectious Diesease Immunoassay Market, By Platform
    7.1 Introduction
    7.2 Chemiluminescence Immunoassay (CLIA)
    7.3 Fluorescence Immunoassay (FIA)
    7.4 Colorimetric Immunoassay (CI)
    7.5 Radioimmunoassay (RIA)
    7.6 Other Platforms

8 Infectious Diesease Immunoassay Market, By Specimen Type
    9.1 Introduction
    9.2 Blood
    9.4 Saliva
    9.5 Urine
    9.6 Other Specimens

9 Infectious Diesease Immunoassay Market, By Disease Type
    9.1 Introduction
    9.2 Hepatitis
    9.4 HIV
    9.5 CT/NG
    9.6 HAIS
    9.7 HPV
    9.8 TB
    9.9 Influenza
    9.10 Others

10 Infectious Diesease Immunoassay Market, By End User
     10.1 Introduction
     10.2 Hospitals and Clinical Laboratories
     10.3 Pharmaceutical & Biotechnology Companies and Cros
     10.4 Research and Academic Laboratories
     10.5 Other End Users

11 Infectious Diesease Immunoassay Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 UK
             11.3.3 France
             11.3.6 Rest of Europe (RoE)
     11.4 Asia Pacific
             11.4.1 China
             11.4.2 India
             11.4.3 Japan
             11.4.4 Rest of Asia Pacific
     11.5 Latin America
     11.6 Middle East and Africa

12 Competitive Landscape
     12.1 Introduction
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends

13 Company Profiles*
     13.1 Introduction
     13.2 Abbott Laboratories, Inc.
     13.3 Siemens AG
     13.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
     13.5 Sysmex Corporation
     13.6 Biom�rieux Sa
     13.7 Ortho Clilnical Diagnostics, Inc.
     13.8 Diasorin
     13.9 Qiagen N.V.
     13.10 Thermo Fisher Scientific, Inc.
     13.11 Becton, Dickinson and Company
     13.12 Bio-Rad Laboratories, Inc.
     13.13 Agilent Technologies

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).

4 0 5 8 3

Manage preferences :

Select all
News-Letters with latest Market insights
Information & discussion on the relevant new products and services
Information & discussion on Market insights and Market information
Information & discussion on our events and conferences
Preferred modes for discussion
- Select all
- Email Phone Professional and social network (Linkedin, etc)

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.